Introduction
Recent advancements in breast cancer treatment using chemotherapy, radiotherapy, and surgery have extended the life expectancy of patients considerably.
1-3 However, serious side effects, low specicity and drug resistance of anticancer drugs have inspired scientists to search for more effective and harmless medication. 4 The tightly regulated apoptosis extrinsic pathway that is triggered via death receptors present on the surface of the cell, and the mitochondrial-dependent intrinsic pathway are the key factors in maintaining cellular homeostasis. 5 Under normal circumstances, Reactive Oxygen Species (ROS) and the cellular antioxidant system exist in balance. Disturbing this balance and collective generation of ROS causes oxidative stress. Findings show that ROS not only functions as a regulator of subcellular events but also is able to induce cell death through the apoptotic pathway. High concentration of ROS causes damage to DNA, proteins and lipids, which can lead to cell death. Furthermore, increasing pieces of evidence suggest that oxidative stress induces mitochondrial dysfunction. 6 Drugs with the ability of inhibiting DNA synthesis are among the best choices to treat fast proliferating cancer cells.
7 DNAsmall molecules interaction leads to signicant modication in DNA structure and may result in hindered or suppressed function of nucleic acids in physiological processes. [8] [9] [10] Therefore, studying the interaction of potential anticancer agents with DNA and understanding their modes of action may help signicantly to design new drugs for clinical use.
11,12 DNA-drug interactions occur via whether covalent or noncovalent (electrostatic interactions, grooves binding, intercalation) binding and small differences in molecular structure may greatly affect the binding modes and as a result the stability of DNA-molecule complexes. 13 Negatively charged DNA phosphate backbone interacts with the positively charged ends of small molecules via electrostatic binding, whereas major and minor groove binding involve hydrogen bonding or van der Waals interaction with nucleic acid bases. On the other hand, intercalation occurs when small molecules intercalate within the nucleic acid base pairs.
12,14 Berenil, bleomycin and distamycin A (groove binding agents), tamoxifen, doxorubicin, daunomycin, quinolones, and quinoxalines (DNA intercalative agents) 12 are some of the successful therapeutic DNA-interacting agents.
Natural products have played a pivotal rule in guiding researchers to develop efficient anticancer agents. 15 Many polysaccharides extracted from natural sources have been found to possess a variety of biological activities and can be classied into two groups based on their sources, 16 natural and semi-synthetic polysaccharides, which are produced by chemical or enzymatic modications of the parent macromolecules. Numerous studies have reported that natural polysaccharides can inhibit tumor cells proliferation either by directly inducing apoptosis or by triggering immunopotentiation activity in combination with chemotherapy.
17 Chitosan (CS), a semi-synthetically bio-based polymer, a deacetylation derivative of chitin (a polysaccharide presents in the exoskeleton of crustaceans, fungi, and insects) under alkaline condition, is a linear copolymer comprised of randomly distributed b-(1/4)-linked 2-amino-2-deoxy-D-glucopyranose and 2-amino-2-deoxy-D-glucopyranose units. [18] [19] [20] Due to favorable properties such as biocompatibility, biodegradability in presence of chitinase, chitosanase, lysozyme, and nontoxicity, this cationic polysaccharide has been widely studied and developed for a variety of biomedical and pharmaceutical applications, including fungistatic and antibacterial, antitumor, anti-inammatory, antioxidant, immunoadjevant, wound healing, tissue engineering, and gene delivery.
21-26
This study has focused on determining the in vitro cytotoxicity of CS in MDA-MB-231, T47D and MCF-7 breast cancer cell lines and its underlying mechanism of action. Furthermore, the in vitro binding characteristics of CS-DNA were explored by using various spectroscopic techniques.
Experimental

Materials and cells
CS (Sigma 448869, low molecular weight 50-190 kDa, 85% deacetylate), MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide), ethidium bromide (EB), acridine orange (AO), Phosphate Buffer Saline (PBS), dimethyl sulfoxide (DMSO), RNAase A, propidium iodide (PI), agarose, DCFH, and rhodamine 123 were supplied by Sigma-Aldrich chemical Co. (St. Louis Mo, USA). MDA-MB-231, MCF-7, T47D and L929 cell lines were purchased from National Cell Bank of Iran (Pasteur Institute, Iran). RPMI-1640, fetal bovine serum (FBS), trypsin-EDTA, penicillin, and streptomycin were purchased from Gibco. The Annexin V-FITC apoptosis detection kit was supplied from BioVision, in situ cell death detection kit, uorescein was obtained from Roche and Caspase-3 colorimetric assay kit was purchased from BIOMOL International, USA.
Preparation of chitosan and DNA solutions
High molecular weight DNA was extracted from rat hepatocyte using standard procedure 27 (all experiments were performed in compliance with the guidelines of Tehran University of medical sciences National Ethics Committee in Biomedical Research) and 1 mg ml À1 DNA stock solutions were prepared in phosphate buffer (0.1 M, pH ¼ 7.4). Extracted DNA quality control was performed by running samples on 0.8% agarose gel to conrm high molecular weight and samples with 260/280 absorbance ratios $1.8 were accepted as pure DNA. Chitosan stock solution (1 mg ml
À1
) was prepared as described previously. 28 Briey, 0.4 g of CS was dissolved in 40 ml 1% (w/w) acetic acid solution. The solution was sonicated using a 30 C ultrasonic bath (Bandlin, Germany) 10 Ten photos were taken of randomly selected areas of the stained slides to ensure the obtained data were representative.
Flow cytometric analysis of apoptosis
CS induced apoptosis was veried by ow cytometry (Partec PAS, Germany) using a commercially available Annexin V-FITC/ PI apoptosis detection kit (BioVision). 2.1 Â 10 6 MDA-MB-231 cells (3.5 Â 10 5 cells per well) were seeded into 6-well plates and treated with the CS IC 50 for 4 h, aerward, cells were harvested and washed with PBS. Cell pellets were labeled with PI, and FITC conjugated Annexin V according to the protocol described by the kit manufacturer. Stained cells were analyzed by ow cytometry.
TUNEL assay for measurement of in situ DNA fragmentation TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling) assay was used for detection of DNA fragmentation, a key event in apoptosis, using in situ cell death detection kit, uorescein (Roche) according to the manufacturer's instruction. Cells were cultured and treated with CS IC 50 concentration for 4 h, then were xed in 4% paraformaldehyde and permeabilized with 1% Triton X-100 and 0.1% sodium citrate. Cells were suspended in PBS and mean cell uorescence of 10 000 cells and percentage of TUNEL-positive cells was analyzed using ow cytometer.
Assessment of changes in mitochondrial transmembrane potential
Measurement of mitochondrial membrane potential changes (DJ m ) was performed with rhodamine 123 uorescent dye. At rst, MDA-MB-231 (3. 
DNA oxidation analysis
Genomic DNA of MDA-MB-231 cells treated for 2 h with 145 and 290 mg ml À1 CS and untreated controls were extracted according to standard phenol/chloroform extraction procedure. 27 8-Oxo detection Elisa kit (Cayman chemical 589320) was used to measure the concentration of the major product of DNA oxidation (8-oxo-2 0 -deoxyguanosine) in each sample according to manufacturer's protocol. In brief 5 mg gDNA was subjected to the Elisa kit in duplicates aer digestion with nuclease P1 (sigma N8630) and treatment with alkaline phosphatase (NEB M0290S) in a total volume of 50 ml. The amounts of 8-oxo were then reported in pg ml À1 .
Caspase-3 activity assay
Caspase-3 activity was measured using colorimetric assay kit (BIOMOL International, USA), according to the manufacturer's instruction. Briey, MDA-MB-231 cells (1 Â 10 6 ) were treated with 70, 145 and 290 mg ml À1 of CS for 4 h and then each sample was harvested and washed with PBS. The cells were incubated with lysis buffer on ice, and the protein concentration of each sample was determined using the Bradford method. Equivalent amounts of proteins for each sample were incubated with the appropriate caspase-3 substrate and aer 4 h; the absorbance at 405 nm was measured using a microplate reader.
Cell cycle analysis
Cell cycle distribution was examined by measuring the DNA content of nuclei labeled with propidium iodide (PI). 3.5 Â 10 5 MDA-MB-231 cells were treated with 145 and 290 mg ml À1 of CS for 24 h. Aer treatment, cells were harvested by centrifugation, washed with 1 ml cold PBS, centrifuged, and xed in 70% cold ethanol at 4 C for 24 h. Subsequently, cells were washed twice and treated with RNase A (20 mg ml À1 ) and PI (20 mg ml À1 ) for 30 min at 37 C in the dark. At the end, cell cycle distribution analysis was performed using ow cytometry and the percentages of cells at G1, S and G2/M phases were calculated by FlowJo soware (Version 7.6.1).
UV-visible spectroscopy
UV absorbance measurements were recorded on Carry spectrophotometer (100 Bio-models, Australia) using quartz cuvettes. Absorption experiments were done by titrating varying concentrations of CS (9-150 mg ml
À1
) against a constant concentration of DNA (50 mg ml À1 ). The UV spectra of CS solution, DNA solution, and CS-DNA complex were recorded in the 190-400 nm range. The spectra of each sample were recorded in 30 min at 298 K. Blank used for each CS-DNA sample, contained the same amount of CS without any DNA.
Fluorescence studies
Fluorescence experiments were carried out on a Carry eclipse spectrouorometer (Australia) using 1 cm quartz cells. In competitive displacement assay with EB, a solution containing EB (2.6 mM) and DNA (50 mg ml À1 ) was titrated with increasing concentrations of CS. EB-DNA complex was excited at 500 nm and emission spectra were recorded from 530-700 nm, with the widths of both the excitation and the emission slits set at 10 nm. ) and CS-DNA were recorded using Aviv circular dichroism 215 spectrophotometer (USA) at 298 K. The CD spectra were recorded at wavelengths between 200-320 nm. Background spectrum of phosphate buffer solution was subtracted from the spectra of DNA, CS, and CS-DNA complex. Then, the spectra of CS-DNA samples were subtracted from the spectra of CS in the same condition.
Statistical analysis
Experimental data processing was carried out using Microso Excel 2013 soware, and results were presented as the mean AE standard deviation of three or more independent experiments. The signicant differences between means were determined by t-test when statistical signicance was P value #0.05.
Results and discussion
Growth inhibitory effect of CS on MCF-7, T47D and MDA-MB-231 breast cancer cells
To investigate the inhibitory effect of CS, three human breast cancer cell lines (MDA-MB-231, T47D, MCF-7) and normal broblast L929 cells were treated with 15.62-500 mg ml À1 CS for 24, 48 and 72 hours. Initial microscopic examination of the cells aer 24 h demonstrated vivid morphological alterations in cancer cells such as cell rounding, detachment, and cytoplasmic vacuolation indicating CS cytotoxicity (Fig. 1) . The physical and biologic properties of chitosan are dependent on its molecular weight (MW) and degree of deacetylation (DD). In previous studies, the cytotoxicity of chitosan as a soluble molecule has been reported as a function of MW, DD, and concentration. 30 In this study, growth inhibition was measured by MTT assay and IC 50 s was calculated. As it is shown in (Fig. 2) , exposure of three breast cancer cell lines to low M w CS with 85% DD clearly decreased cellular viability in a dose and timedependent manner while inducing a much less toxic effect on normal L929 cells, indicating a favorable selectivity towards cancer cells. Among the breast cancer cell lines tested, MDA-MB-231 is a highly invasive, basal-like phenotype 31 and oen considered as an apoptosis-resistant cell line.
32 Therefore, to investigate the mechanism by which CS decreases cell viability in breast cancer cells, we focused on MDA-MB-231 cells.
CS induces apoptosis in MDA-MB-231 cells
In order to verify apoptosis as the underlying mechanism of CS growth inhibitory effect, AO/EB staining, Annexin V-FITC/PI staining, and TUNEL assay were performed. In AO/EB staining of MDA-MB-231, T47D and MCF-7 cells as shown in Fig. 3A , cell nuclei and cell membrane integrity of control samples did not change signicantly, while treated samples showed different extents of chromatin condensation, nuclear fragmentation, and destruction of cell membrane integrity. To further conrm apoptosis, MDA-MB-231 cells were treated with IC 50 concentration (290 mg ml À1 ) of CS for 4 h and apoptosis induction was evaluated by Annexin V-FITC/PI double staining. Annexin V-FITC is capable of binding tightly to phosphatidylserines externalized to outer plasma membrane during early stages of apoptosis, and simultaneously, propidium iodide is included to differentiate between apoptotic and necrotic cells. This approach allows a further distinction of early apoptotic (Annexin V+/PIÀ) and late apoptotic/necrotic (Annexin V+/PI+) cells. The results (Fig. 3B) indicated that CS markedly induces apoptosis, and the population of early apoptotic cells was 34%, higher than the untreated samples. DNA fragmentation is a major hallmark of apoptosis which reects the endonuclease activity and can be evaluated quantitatively by TUNEL assay. As shown in Fig. 3C , DNA fragmentation in MDA-MB-231 cells treated with IC 50 concentration of CS for 4 h, quantied by ow cytometry and compared to untreated control cells 21.9% apoptosis was observed.
CS induces apoptosis via ROS generation
In order to examine the changes in intracellular ROS level and ROS involvement in apoptosis induced by CS, DCFH-DA assay was conducted on MDA-MB-231 cells treated with 70, 145 and 290 mg ml À1 CS for 12 h and 9.29, 13.40 and 20.50% increase in ROS generation was observed respectively, whereas, untreated cells showed only 3.69% DCF positive cells (Fig. 4A) . These results indicate that CS is able to trigger ROS generation in a dose-dependent manner in treated cells.
DNA oxidation
Increased level of ROS in CS treated cells may have caused DNA damage via DNA oxidation. Therefore, to investigate the effect of CS on DNA oxidation, accumulation of 8-oxoguanine (8-oxo) which is the most abundant oxidative base lesion in genomic DNA was evaluated. As shown in Fig. 4B , treatment of MDA-MB-231 cells with 145 and 290 mg ml À1 CS for 2 h has resulted in formation of 350.9 and 553.4 pg ml À1 8-oxo respectively, which is signicantly higher in comparison to untreated cells (131.6 pg ml À1 ). DJ m is a key event in mitochondrial apoptotic pathway, and reduces along with the increase in mitochondrial membrane permeability. A dose-dependent increase in the mean percentage of depolarization and reduction of DJ m aer treatment with CS was observed, which indicates the mitochondrial pathway involvement in the apoptosis induced by CS. Treatment of MDA-MB-231 cells for 12 h with 145 and 290 mg ml À1 of CS resulted in 10.9 and 19.5% decrease in functional mitochondria respectively, compared to untreated cells (Fig. 4C) .
CS increases caspase-3 activity in MDA-MB-231 cells
Caspase-3 is probably the best understood executioner in apoptosis and is crucial for some typical hallmarks of apoptosis such as apoptotic chromatin condensation, DNA fragmentation, and formation of apoptotic bodies. In this study, caspase-3 activation was evaluated in MDA-MB-231 cells incubated with 70, 145, and 290 mg ml À1 of CS for 4 h, and compared to the negative control, 2.3, 2.6, and 3.1 times increase in caspase-3 activity was observed respectively (Fig. 4D ). This indicates that CS has induced the expression of this caspase, and the apoptosis could be triggered through a caspase-dependent process.
CS treated MDA-MB-231 cells exhibit cell cycle arrest in S phase
To further investigate the mechanism, underlying the CS inhibitory activity on breast cancer cells, we investigated its effect on cell cycle progression. Hence, we monitored cell cycle phase distribution of MDA-MB-231 cells aer treating with 50% IC 50 and IC 50 concentrations of CS for 24 h, and subsequently, cell cycle proles were analyzed by measuring the DNA content using ow cytometry. As shown in Fig. 5 , treating cells with 145 and 290 mg ml À1 of CS caused substantial inhibition of cell cycle progression. The cells population in S phase increased from 8 to 21%, and an increase in subG1 population was observed. There was also a decrease in the number of cells in the G1 and G2/Mphases. These results suggest that CS disturbs cell cycle progression, leading to the accumulation of cells in S-phase.
UV-visible spectra observation of CS-DNA complexes
UV-visible absorption spectrum is a basic, most common and simple method, which helps in illustrating the structural changes and also sheds light on complex formation. 33, 34 In this study, this method was used to observe the changes of DNA absorbance spectrum in the presence of different concentrations of CS. The absorption spectra of DNA scanned in UV region in the absence and presence of different concentrations of CS (9-150 mg ml À1 ) at pH ¼ 7.4 as shown in Fig. 6A1 and A2.
In this region, DNA displays a peak at 260 nm (indole groups) and 210 nm (sugar-phosphate groups), while, CS has no absorption in this area. When different concentrations of CS was added to DNA, hyperchromism was observed without any noticeable shi in the position of maximum absorption peak, which clearly indicated the formation of complex between DNA and CS. 35 The exact binding mode cannot be proven simply by this technique, hence, further tests were necessary to explore the mode of interaction.
Competitive displacement uorescence assay
To further explore the binding mode of CS with DNA, competitive displacement uorescence assay was performed. As the intrinsic uorescence of DNA is very weak, we used Ethidium Bromide (EB) as a uorescent probe to study the interaction between DNA and CS. 36 In aqueous solutions, free EB is not considerably uorescent. However, in the presence of DNA, it is strongly emissive due to its intercalation within the DNA base pairs. Since EB intercalates DNA, competitive displacement of EB on the addition of drug will be indicative of an intercalative binding mode. 37 In this study, uorescence quenching studies were performed by keeping the xed concentration of DNA (50 mg ml À1 ) and varying amounts of CS (0-448 mg ml À1 ). CS did not uoresce at 600 nm when excited at 500 nm, and as the emission spectra of the DNA-EB system is shown in Fig. 6B1-B3 , with increasing concentrations of CS, a remarkable reduction in uorescence of DNA-EB system was observed, which suggests CS has substituted EB in the DNA-EB system and dissociated the EB into the solvent. This leads to a decrease in the uorescence intensity of the DNA-EB system and has provided direct evidence in support of intercalative binding mode. Moreover, the uorescence quenching data were analyzed to obtain the quenching constant (K SV ) by using the Stern-Volmer equation:
where, F 0 and F are the steady-state uorescence intensities in the absence and presence of quencher (CS), respectively. K SV is the Stern-Volmer quenching constant, and [Q] is the concentration of the quencher. Hence, the slope of linear regression of F 0 /F vs.
[Q] plot yields the K SV value. The quenching constant (K SV ) of EB by CS in the presence of DNA was calculated to be 2.5 Â 10 5 M À1 which is consistent with K SV of most of the intercalating agents, 12 and suggesting that CS molecules have intercalated into the base pairs of DNA. Furthermore, linear Stern-Volmer plots were obtained for CS, suggesting that dynamic quenching process might have occurred. The constant parameter (K and n) can be calculated using the following equation: , which indicates that CS has a high affinity towards dsDNA, and number of binding sites (n) of the CS-DNA complex is 1.09. These parameters of the CS-DNA complex suggesting that CS can intercalate into DNA base pairs strongly.
39
Circular dichroism study
To further conrm the interaction modes of the CS with DNA, the conformational changes of DNA in the absence and presence of small molecules was studied by CD spectroscopy. Generally, base stacking and right-handed helicity in B-form dsDNA creates a positive band at 275 nm and a negative band at 245 nm in CD spectrum respectively. 40 Small molecules different binding modes of interaction with DNA may cause diverse perturbation in base stacking, which can be detected via changes in CD signals. Classical intercalation oen leads to changes in the intensities of both bands due to enhancement of base stacking and stabilization of helicity, whereas simple groove binding and electrostatic interaction produce low or no perturbation on the base stacking and helicity bands.
33 Fig. 7 shows that at the presence of CS, the intensity of the positive band at 275 nm and negative band at 245 nm increases remarkably, which indicates that CS mainly intercalates into DNA base pairs and enhances the base stacking.
Conclusions
Previous studies have reported the potential of CS to induce apoptosis in leukemia, gastric, bladder and breast cancer cells. However, underlying cellular and molecular mechanism for antitumor properties of CS has not been elucidated. 23, 41 In the present study, we demonstrated that CS is cytotoxic towards MDA-MB-231, MCF-7, and T47D breast cancer cell lines via inducing apoptosis, while, non-toxic to non-carcinogenic L929 cells. Our results indicate that CS may selectively inhibit the viability of breast cancer cells, which is a highly desirable property of potential anticancer agents. The mitochondriamediated cell death pathway also referred as the intrinsic apoptotic pathway is at the center of the apoptosis induced by the caspase signaling cascade activation, and plays a pivotal role in the apoptotic cell death induced by anti-cancer agents. High levels of ROS trigger mitochondrial permeability transition pore opening (DJ m loss), which is an important downstream signal of ROS, and the release of pro-apoptotic factors and the activation of caspase-3. Caspase-3 activation subsequently leads to DNA breakage, nuclear chromatin condensation, and apoptosis. 6, [42] [43] [44] As our data show, CS has induced intrinsic mitochondria-mediated apoptosis in a caspase-3-dependent manner, accompanying collapse of mitochondrial membrane potential and ROS production from mitochondria into the cytoplasm. This indicates that mitochondrial dysfunction may have occurred during CS-induced MDA-MB-231 cells death.
Cancer cells proliferate relentlessly due to loss of cell cycle checkpoints that regulate the passage through the cell cycle. These check points monitor the integrity of DNA and ensure proper gene expression. Cell cycle analysis revealed an "Sphase" population increase in a concentration-dependent manner which indicates that CS can induce S phase cell cycle arrest in treated MDA-MB-231 cells. Besides, when MDA-MB-231 cells were treated for 24 h, an increase in cells in subG1 phase was observed. This suggests that CS might have induced apoptosis or DNA damage, which needs to be repaired before cell division took place. Since DNA replication is an essential phase of the cell cycle, and DNA is a bio-receptor for vast numbers of small molecules, it is considered a major biological target for anti-cancer agents. Intercalation of small molecules into DNA may be applied in therapeutic approaches to arrest cell proliferation and destroy tumor cells, or in the case of infected tissues, by preventing/inhibiting synthesis of DNA and gene transcription. 45 Therefore, interaction properties of CS with DNA were investigated and the results were discussed. Previous studies have proposed that CS and its derivatives form complex with DNA by electrostatic interactions between primary amine groups of chitosan and anionic phosphate backbone of DNA. This binding protects the DNA from nuclease degradation and transfect DNA into different cell types. 22, 46 Here, the UV-visible, competitive uorescence measurements and CD analysis have revealed the ability of CS to interact with DNA via intercalation with strong binding affinity. Noncovalent binders such as intercalating agents are known to induce toxicity in cancer cells by triggering apoptosis. In addition, some of these agents induce cytotoxicity via cell cycle arrest in rapidly dividing cells. To sum up, regarding specic antiproliferative activity of CS towards breast cancer cells, our results conrmed the potential of using CS as an anti-cancer agent compound.
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